TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Juno Therapeutics Inc (NASDAQ:JUNO) Investor Lawsuit Against Acquisition By Celgene Corporation Filed

  • If you purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO) and currently hold any of those NASDAQ:JUNO shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

An investor, who currently holds shares of Juno Therapeutics Inc (NASDAQ:JUNO), filed a lawsuit in effort to halt the proposed takeover of Juno Therapeutics Inc. by Celgene Corporation for $87 per share. Seattle, WA based Juno Therapeutics Inc is a biopharmaceutical company, which is focused on developing cellular immunotherapies for the treatment of cancer. Juno Therapeutics Inc rep...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: